Quick update for shareholders and prospective investors. We closed our Tier 2 $6.85 level with 43,126 shares sold. The SEC approved our Tier 3 with another share […]
This is Jim Segermark, CEO and Co-Founder of InSitu Biologics. Quick note to share our progress and upcoming events with you. If you live, or happen to […]